Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Registry following people with diabetes in an Israeli health plan

Records diabetes patients, tracking how their illness and risk factors change over time.

Plain-language title generated from the registry record
Registry title: Registry of Diabetes Patients in a Large Health Maintenance Organization in Israel

Key facts

Where
Tel Aviv, IsraelSee the site

Where in Israel

  • Maccabi Healthcare ServicesTel Aviv, IsraelNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Maccabi Healthcare Services, Israel
Trial code
NCT01779115
Record updated
31 January 2013
Original description
A computerized registry of diabetes patients in a large health maintenance organization in Israel. The registry is aimed to be used by health professionals to identify diabetes patients and to follow the courses of their illnesses and risk factors.Read full original descriptionShow less

Computerized Registry of Diabetes Patients in a Large Health Maintenance Organization in Israel

A computerized registry of diabetes patients in a large health maintenance organization in Israel. The registry is aimed to be used by health professionals to identify diabetes patients and to follow the courses of their illnesses and risk factors.

Inclusion: Diabetic patient was defined according to the criteria suggested by American Diabetes Association - symptoms diagnosed as diabetes and fasting plasma glucose >125 mg/dl (7.0 lmol/l) or casual (namely, any time of day without regard to time since last meal) plasma glucose concentration P200 mg/dl. In order to reach maximal validity, we also included any patient who answered to one of the following: (1) purchased at least two hypoglycemic medications or single insulin dose during 6 months. (2) Had HbA1c result of at least 7.25%. HbA1c of 6.5% was used as entry criterion to registry only when the patient was diagnosed as diabetic.

ClinicalTrials.gov NCT01779115